KIC
TMO icon

Kensington Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Kensington Investment Counsel’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317K Sell
632
-376
-37% -$180K 0.14% 77
2026
Q1 		$495K Sell
1,008
-205
-17% -$111K 0.24% 68
2025
Q4 		$703K Sell
1,213
-6
-0.5% -$3.39K 0.29% 76
2025
Q3 		$591K Sell
1,219
-31
-2% -$14.4K 0.24% 79
2025
Q2 		$507K Sell
1,250
-197
-14% -$82.4K 0.22% 78
2025
Q1 		$720K Hold
1,447
– – 0.32% 73
2024
Q4 		$753K Sell
1,447
-27
-2% -$14.8K 0.31% 76
2024
Q3 		$912K Sell
1,474
-13
-0.9% -$7.7K 0.38% 74
2024
Q2 		$822K Sell
1,487
-6
-0.4% -$3.44K 0.36% 74
2024
Q1 		$868K Buy
1,493
+175
+13% +$98.2K 0.4% 71
2023
Q4 		$700K Buy
1,318
+31
+2% +$15K 0.37% 74
2023
Q3 		$651K Sell
1,287
-34
-3% -$18.1K 0.4% 72
2023
Q2 		$689K Sell
1,321
-295
-18% -$159K 0.44% 69
2023
Q1 		$931K Sell
1,616
-23
-1% -$13K 0.7% 54
2022
Q4 		$903K Sell
1,639
-78
-5% -$41.3K 0.71% 59
2022
Q3 		$871K Sell
1,717
-96
-5% -$53.7K 0.73% 58
2022
Q2 		$985K Buy
+1,813
New +$998K 0.84% 57

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Kensington Investment Counsel's TMO Position: Q2 2026 in Review

Kensington Investment Counsel reduced its Thermo Fisher Scientific (TMO) stake by 37% in Q2 2026, selling an estimated $180K and leaving 632 shares worth $317K. The position accounts for 0.14% of the portfolio, ranked #77.

Kensington Investment Counsel first reported a position in TMO in Q2 2022 and has held it in 17 quarters since. The position peaked at $985K in Q2 2022. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Kensington Investment Counsel held 632 shares of Thermo Fisher Scientific worth $317K as of Q2 2026.
  • Kensington Investment Counsel sold 376 Thermo Fisher Scientific shares in Q2 2026, an estimated $180K.
  • Thermo Fisher Scientific made up 0.14% of Kensington Investment Counsel's portfolio in Q2 2026, its #77 holding.
  • Kensington Investment Counsel first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 17 quarters since.
  • Kensington Investment Counsel's Thermo Fisher Scientific position peaked at $985K in Q2 2022.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kensington Investment Counsel's 13F filing for Q2 2026, filed 14 Aug 2026.